Turkey has loosened manufacturing rules to now allow pharmaceutical products for human use and food product supplements to be produced on the same sites as veterinary pharmaceutical products, under certain conditions.
The Regulation Amending the Regulation on the Veterinary Pharmaceutical Products ("Amendment Regulation") was published in Official Gazette number 30424 on 17 May 2018.
Under the Amendment Regulation, pharmaceutical products for human use and food product supplements can be now manufactured in an appropriate form and category on the same sites which are authorised to manufacture veterinary pharmaceutical products. Manufacturers must take appropriate measures to prevent the risk of cross-contamination and obtain approval from the General Directorate of Food and Control.
However, manufacturing sites operating with living active substances cannot be used as a common area for human and veterinary pharmaceutical products.
Please see this link for the full text of the Amendment Regulation (only available in Turkish).
Information first published in the MA | Gazette, a fortnightly legal update newsletter produced by Moroğlu Arseven.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
